Eton replaces auditor KMJ Corbin with Crowe after KMJ partners join Crowe; no disagreements

Eton Pharmaceuticals, Inc.

KMJ Corbin resigned as independent auditor effective June 14, 2024; Crowe appointed same day with Audit Committee approval.
Partners and professional staff of KMJ joined Crowe, triggering the resignation and appointment.
KMJ's reports for fiscal 2022 and 2023 contained no adverse opinion or modification.
No disagreements or reportable events between Eton and KMJ during those periods or the subsequent interim period.
KMJ provided a letter agreeing with the company's statements, filed as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.